Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Farber

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of the American Osteopathic Association|May 11, 2002
Herbal medications should undergo rigorous evaluationAndrew Farber, Robin B McFee
Nature Communications|May 4, 2026
Characterization of KRAS<sup>G12C</sup> inhibitor olomorasib single-agent and combination with activity in KRAS<sup>G12C</sup>-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of the American Osteopathic Association|May 11, 2002
Herbal medications should undergo rigorous evaluationAndrew Farber, Robin B McFee
Nature Communications|May 4, 2026
Characterization of KRAS<sup>G12C</sup> inhibitor olomorasib single-agent and combination with activity in KRAS<sup>G12C</sup>-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.
Pageof 1